FdaApplication
ANDA 091025
Identifiers
- fda_app_no: ANDA091025
Properties
| Property | Value |
|---|---|
| applicant_name | ACTAVIS ELIZABETH LLC |
| application_type | ANDA |
| approval_date | 2020-07-09 |
Products (8)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| PREGABALIN | PREGABALIN | 150MG | CAPSULE;ORAL |
| PREGABALIN | PREGABALIN | 200MG | CAPSULE;ORAL |
| PREGABALIN | PREGABALIN | 300MG | CAPSULE;ORAL |
| PREGABALIN | PREGABALIN | 25MG | CAPSULE;ORAL |
| PREGABALIN | PREGABALIN | 225MG | CAPSULE;ORAL |
| PREGABALIN | PREGABALIN | 100MG | CAPSULE;ORAL |
| PREGABALIN | PREGABALIN | 50MG | CAPSULE;ORAL |
| PREGABALIN | PREGABALIN | 75MG | CAPSULE;ORAL |
8 products